Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Active not recruiting 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Leukemia, Myeloid, Acute 162Myelodysplastic Syndromes 46Leukemia, Myelomonocytic, Chronic 26Leukemia 16Myeloproliferative Disorders 11Recurrence 9Hematologic Neoplasms 8Leukemia, Biphenotypic, Acute 7Primary Myelofibrosis 6Neoplasms 6Lymphoma, T-Cell, Peripheral 6Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Anemia, Refractory, with Excess of Blasts 5Neoplasm, Residual 4Multiple Myeloma 4Lymphoma, Non-Hodgkin 4Leukemia, Monocytic, Acute 4Hematologic Diseases 4GATA2 Deficiency 4Precursor Cell Lymphoblastic Leukemia-Lymphoma 3Pathologic Complete Response 3Pancreatic Neoplasms 3Neoplasm Metastasis 3Myelodysplastic-Myeloproliferative Diseases 3Lymphoma 3Leukemia, Lymphocytic, Chronic, B-Cell 3Hodgkin Disease 3Carcinoma, Non-Small-Cell Lung 3Breast Neoplasms 3Sarcoma 2

Interventions

Cytarabine 3Injections 2Idarubicin 2Gemtuzumab 2Filgrastim 2Decitabine 2veliparib 1fludarabine phosphate 1aldesleukin 1Whole-Body Irradiation 1Temozolomide 1Peripheral Blood Stem Cell Transplantation 1Granulocyte Colony-Stimulating Factor 1Etoposide 1Daunorubicin 1CPX-351 1Busulfan 1Bone Marrow Transplantation 1Azacitidine 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Leukemia, Myelomonocytic, Acute × Azacitidine × 1 year × Clear all
NCT00658814 2026-05-29

Azacitidine and Gemtuzumab Ozogamicin in Treating Older Patients With Previously Untreated Acute Myeloid Leukemia

National Cancer Institute (NCI)

Phase 2 Active not recruiting
133 enrolled 10 charts
Other hematologic neoplasm

Leukemia, Erythroblastic, Acute, Leukemia, Megakaryoblastic, Acute, Leukemia, Monocytic, Acute, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡